DEVICE CATEGORY · PGQ
Cochlear Implant With Combined Electrical Stimulation And Acoustic Amplification
Intended to provide electric stimulation to the mid to high frequency region of the cochlea and acoustic amplification to the low frequency regions, for patients with residual low frequency hearing sensitivity.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cochlear Hybrid Implant SystemP130016/S061 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Cochlear Hybrid Implant SystemP130016/S060 | Cochlear Americas | PMA supplement | Apr 30, 2026 | FDA |
Nucleus Hybrid L24 Cochlear Implant SystemP130016/S058 | Cochlear Americas | PMA supplement | Oct 16, 2025 | FDA |
| Cochlear Americas | PMA approval | Mar 20, 2014 | FDA |
Source information
Follow the FDA links to view the original records.

